Latest Health News

Tyro Payments Limited reported a solid 5% increase in gross profit and a 72% surge in statutory profit before tax for H1 FY26, underpinned by growth in core payment volumes and banking activities. The company also expanded its fintech footprint with the acquisition of AI-powered platform Thriday.

Etherstack plc reported a robust FY2025 financial rebound with revenue soaring 70% to US$10.1 million, driven by major US project deliveries and a 62% rise in recurring support revenues. The company also turned EBITDA positive and secured key long-term contracts, setting the stage for strong growth in 2026.

Emerald Resources NL reported a 23% rise in half-year profit to $73.1 million, underpinned by solid gold production at its Okvau Gold Mine and significant progress across its Cambodian and Australian projects.

Singular Health Group reported a 55% rise in net loss to $2.97 million for H1 FY2026, driven by share-based payments and strategic hires, while making significant progress in US commercial deployments and securing FDA clearance for its cloud-based 3D medical imaging platform.

NZME Limited has reported a significant turnaround in 2025, posting a statutory net profit after tax of NZD 13.1 million and a 15% increase in operating EBITDA, underpinned by strong digital revenue growth across its divisions.

Apiam Animal Health has officially become a wholly owned subsidiary of Adamantem Capital's entities following a scheme of arrangement, with shareholders receiving a special dividend and a mix of cash and shares. The company will soon be delisted from the ASX.

Neurotech International has reported positive long-term safety results for its lead drug candidate NTI164, bolstering its path towards regulatory approval and chronic use in paediatric neurological disorders.

Argent BioPharma has completed its largest commercial shipment of CannEpil® to Ireland, marking a key milestone in its European expansion with a delivery valued at approximately AUD 783,000. The product is fully reimbursed under Ireland’s National Health Insurance scheme, enhancing patient access for refractory epilepsy treatment.

Regis Healthcare reported a strong 18.4% revenue increase to $667.7 million for H1 2026, despite a 44.8% drop in statutory net profit. The company expanded its aged care portfolio through key acquisitions and declared a fully franked interim dividend.

nib holdings limited reported a stable net profit of $82.9 million for the half year ended 31 December 2025, supported by 6% revenue growth and disciplined expense management. The Board declared a fully franked interim dividend of 13.0 cents per share.

Biome Australia Limited has reported a robust half-year performance, with revenues climbing nearly 40% and net profit more than doubling, driven by strong product momentum and strategic investments.

Mesoblast Limited is set to release its half-year financial results and operational update, spotlighting its FDA-approved cell therapy and expanding international partnerships.